Impact of Obesity and Weight-Loss Interventions on Immune-Surveillance Mechanisms

肥胖和减肥干预措施对免疫监视机制的影响

基本信息

项目摘要

DESCRIPTION (provided by applicant): Robust T cell mediated immune responses are key components of protection from infection and certain cancers. Emerging evidence suggests that, apart from increased incidence of cardiovascular diseases and cancers, obesity also compromises T cell dependent immune-surveillance mechanisms in mice with increased risk and severity of infections. It is recognized that thymic export of T cells establishes the size and diversity of human naive T cell repertoire. Intriguingly, by middle age, thymus undergoes a process of involution characterized by reduced naive T cell production together with replacement of thymic space with adipocytes. Dietary-obesity is known to increase lipid deposition in several ectopic sites such as muscle, liver and compromise organ function. Similarly, we have shown that obesity in mice exacerbates the mechanisms that promote deposition of ectopic lipid-bearing adipocyte in thymus and reduces generation of naive T cells from thymus. Based on our data from mouse models that obesity restricts T cell receptor (TCR) repertoire diversity and preliminary findings in obese humans, we propose to test the hypothesis that, obesity accelerates immunosenescence and excess weight-loss can rescue loss of thymopoiesis and restriction of T cell repertoire diversity and function in humans. The overall goal of this project is to assess specific hypotheses and predictions about the relationship between obesity and immune system - in particular, thymopoiesis and T cell-mediated immunity - with implications for understanding the mechanisms whereby weight-loss might enhance immune- surveillance in humans. Therefore, we propose to study the impact of obesity and subsequent weight-loss through bariatric surgery and caloric restriction on functional thymic content, thymopoiesis, T cell function and TCR diversity in humans. We propose three specific aims, 1) To test the prediction that obesity increases ectopic adipocyte development in thymus. 2) To test the prediction that obesity lowers thymopoiesis and compromises T cell function. 3) To test the prediction that obesity-induced reduction in functional thymic space, thymopoiesis, and aberrant immune function can be rescued by weight-loss therapy. PUBLIC HEALTH RELEVANCE: Obesity is associated with increased risk and severity of infections and cancers. T cell mediated immune- surveillance is vital for protection against pathogens as well as certain cancers. To date, no studies in humans have evaluated whether obesity impacts the protective T cell immune function. The overall goal of this project is to determine the mechanism of immune dysfunction in obesity and investigate the impact of distinct weight loss treatments on reversing the decline in immunity.
描述(由申请人提供):强大的T细胞介导的免疫反应是保护免受感染和某些癌症的关键组成部分。新出现的证据表明,除了心血管疾病和癌症的发病率增加外,肥胖还损害了感染风险和严重程度增加的小鼠的T细胞依赖的免疫监视机制。T细胞的胸腺输出决定了人类原始T细胞库的大小和多样性。有趣的是,到了中年,胸腺经历了一个退化过程,特征是幼稚T细胞产生减少,胸腺间隙被脂肪细胞取代。众所周知,饮食肥胖会增加肌肉、肝脏等异位部位的脂肪沉积,损害器官功能。同样,我们已经证明,小鼠的肥胖加剧了促进胸腺异位含脂脂肪细胞沉积的机制,并减少了胸腺原始T细胞的生成。基于我们的小鼠模型中肥胖限制T细胞受体(TCR)谱多样性的数据和肥胖人类的初步发现,我们建议验证这样的假设:肥胖加速免疫衰老,过度减肥可以挽救人类胸腺生成的丧失和T细胞谱多样性和功能的限制。这个项目的总体目标是评估关于肥胖和免疫系统--特别是胸腺生成和T细胞介导的免疫--之间关系的具体假设和预测,以帮助理解减肥可能增强人类免疫监视的机制。因此,我们建议通过减肥手术和热量限制来研究肥胖和随后的体重减轻对人类胸腺功能、胸腺生成、T细胞功能和TCR多样性的影响。我们提出了三个具体目标:1)检验肥胖增加胸腺异位脂肪细胞发育的预测。2)检验肥胖会降低胸腺生成并损害T细胞功能的预测。3)验证肥胖所致的功能性胸腺空间减少、胸腺生成和免疫功能异常可通过减肥治疗来挽救的预测。 公共卫生相关性:肥胖与感染和癌症的风险和严重性增加有关。T细胞介导的免疫监视对于预防病原体和某些癌症至关重要。到目前为止,还没有对人类的研究评估肥胖是否影响保护性T细胞免疫功能。该项目的总体目标是确定肥胖患者免疫功能障碍的机制,并调查不同的减肥治疗对扭转免疫功能下降的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VISHWA DEEP DIXIT其他文献

VISHWA DEEP DIXIT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VISHWA DEEP DIXIT', 18)}}的其他基金

Caloric restriction-driven immunometabolic checkpoints of inflammation
热量限制驱动的炎症免疫代谢检查点
  • 批准号:
    10457565
  • 财政年份:
    2022
  • 资助金额:
    $ 39.3万
  • 项目类别:
Yale Murine-TMC on Immune Cell Senescence Derived Inflammation
耶鲁小鼠-TMC 对免疫细胞衰老引起的炎症的研究
  • 批准号:
    10675111
  • 财政年份:
    2022
  • 资助金额:
    $ 39.3万
  • 项目类别:
Caloric restriction-driven immunometabolic checkpoints of inflammation
热量限制驱动的炎症免疫代谢检查点
  • 批准号:
    10656332
  • 财政年份:
    2022
  • 资助金额:
    $ 39.3万
  • 项目类别:
Immunometabolic regulation of bone inflammaging
骨炎症的免疫代谢调节
  • 批准号:
    10430514
  • 财政年份:
    2022
  • 资助金额:
    $ 39.3万
  • 项目类别:
Immunometabolic regulation of bone inflammaging
骨炎症的免疫代谢调节
  • 批准号:
    10641819
  • 财政年份:
    2022
  • 资助金额:
    $ 39.3万
  • 项目类别:
Yale Murine-TMC on Immune Cell Senescence Derived Inflammation
耶鲁小鼠-TMC 对免疫细胞衰老引起的炎症的研究
  • 批准号:
    10553032
  • 财政年份:
    2022
  • 资助金额:
    $ 39.3万
  • 项目类别:
Impact of dysbiosis on the development of age-related inflammation
生态失调对年龄相关炎症发展的影响
  • 批准号:
    10331167
  • 财政年份:
    2020
  • 资助金额:
    $ 39.3万
  • 项目类别:
Impact of dysbiosis on the development of age-related inflammation
生态失调对年龄相关炎症发展的影响
  • 批准号:
    10396668
  • 财政年份:
    2020
  • 资助金额:
    $ 39.3万
  • 项目类别:
Impact of dysbiosis on the development of age-related inflammation
生态失调对年龄相关炎症发展的影响
  • 批准号:
    10667392
  • 财政年份:
    2020
  • 资助金额:
    $ 39.3万
  • 项目类别:
Impact of dysbiosis on the development of age-related inflammation
生态失调对年龄相关炎症发展的影响
  • 批准号:
    10259710
  • 财政年份:
    2020
  • 资助金额:
    $ 39.3万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.3万
  • 项目类别:
    Research Grant
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    $ 39.3万
  • 项目类别:
    Operating Grants
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
  • 批准号:
    10083718
  • 财政年份:
    2023
  • 资助金额:
    $ 39.3万
  • 项目类别:
    Small Business Research Initiative
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 39.3万
  • 项目类别:
    Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
  • 批准号:
    22KJ1758
  • 财政年份:
    2023
  • 资助金额:
    $ 39.3万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
  • 批准号:
    BB/Y000927/1
  • 财政年份:
    2023
  • 资助金额:
    $ 39.3万
  • 项目类别:
    Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
  • 批准号:
    10795212
  • 财政年份:
    2023
  • 资助金额:
    $ 39.3万
  • 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
  • 批准号:
    23K18249
  • 财政年份:
    2023
  • 资助金额:
    $ 39.3万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    $ 39.3万
  • 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    $ 39.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了